DNB Markets upgraded Novo Nordisk to Buy from Hold with a DKK 1,000 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVO:
- Novo Nordisk price target raised to DKK 930 from DKK 800 at Morgan Stanley
- Novo Nordisk call volume above normal and directionally bullish
- Novo Nordisk price target raised to DKK 850 from DKK 650 at Berenberg
- Vivani announces NPM-115 preclinical weight loss data vs. Ozempic /Wegovy
- Viking Therapeutics soars after obesity drug trial hits targets